YCT-529, a hormone-free male birth control pill, has shown high effectiveness in animals and is now in human trials, marking ...

As the indications and demand for glucagon-like peptide-1 (GLP-1) agonist drugs continue to expand, the real-world GLP-1 research and data-driven insights from Prime Therapeutics LLC (Prime) help ...

Researchers at the University of Minnesota have developed YCT-529, a non-hormonal male birth control pill showing efficacy in ...

Research from the University of Minnesota College of Pharmacy, published in Communications Medicine, has laid the groundwork ...

A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...

While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...

MINNEAPOLIS — The University of Minnesota College of Pharmacy released research Wednesday that lays the groundwork for the ...

As part of its strategic expansion, Pentec has partnered with Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, to deliver distribution and ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...